MA
PPH icon

MUFG Americas’s VanEck Pharmaceutical ETF PPH Stock Holding History

MUFG Americas’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,050
Closed -$61K – 1127
2017
Q3 		$61K Hold
1,050
– – ﹤0.01% 544
2017
Q2 		$62K Sell
1,050
-102
-9% -$5.77K ﹤0.01% 535
2017
Q1 		$64K Sell
1,152
-51
-4% -$2.77K ﹤0.01% 539
2016
Q4 		$63K Hold
1,203
– – ﹤0.01% 547
2016
Q3 		$69K Sell
1,203
-680
-36% -$40.8K ﹤0.01% 552
2016
Q2 		$110K Sell
1,883
-102
-5% -$5.95K ﹤0.01% 485
2016
Q1 		$114K Sell
1,985
-375
-16% -$22.2K ﹤0.01% 500
2015
Q4 		$154K Hold
2,360
– – 0.01% 465
2015
Q3 		$149K Sell
2,360
-60
-2% -$4.22K 0.01% 485
2015
Q2 		$171K Hold
2,420
– – 0.01% 477
2015
Q1 		$170K Sell
2,420
-145
-6% -$9.83K 0.01% 500
2014
Q4 		$165K Hold
2,565
– – 0.01% 512
2014
Q3 		$163K Sell
2,565
-135
-5% -$8.36K 0.01% 522
2014
Q2 		$168K Sell
2,700
-180
-6% -$10.7K 0.01% 506
2014
Q1 		$168K Sell
2,880
-200
-6% -$11.3K 0.01% 506
2013
Q4 		$164K Sell
3,080
-250
-8% -$12.7K 0.01% 508
2013
Q3 		$159K Sell
3,330
-2,240
-40% -$106K 0.01% 535
2013
Q2 		$254K Buy
+5,570
New +$258K 0.01% 821

Other funds holding PPH

MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

MUFG Americas's PPH Position: Q4 2017 in Review

MUFG Americas sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2017, closing a stake of 1,050 shares — an estimated $61K sold.

MUFG Americas first reported a position in PPH in Q2 2013 and held it in 18 quarters. The position peaked at $254K in Q2 2013. 50 funds tracked by Wall St. Rank hold PPH as of Q4 2017.

  • MUFG Americas reported no remaining VanEck Pharmaceutical ETF position as of Q4 2017 after selling out during the quarter.
  • MUFG Americas sold 1,050 VanEck Pharmaceutical ETF shares in Q4 2017, an estimated $61K.
  • MUFG Americas first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and held it in 18 quarters.
  • MUFG Americas's VanEck Pharmaceutical ETF position peaked at $254K in Q2 2013.
  • 50 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2017.

Based on MUFG Americas's 13F filing for Q4 2017, filed 8 Feb 2018.